– First patient treatment marks successful initiation of multi-center pilot study in Alpha DaRT U.S. pancreatic cancer program – – Study explores Alpha DaRT® combined with chemotherapy in patients ...
JERUSALEM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (DRTS) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, today announced that the ...
Alpha Tau Medical Ltd., a company specializing in innovative alpha-radiation cancer therapy, announced that CFO Raphi Levy will present at two investor conferences in May 2025. He will participate in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results